Clinical trials referenced in this document:
Documents that mention this clinical trial
Lactobacillus rhamnosus PL1 and Lactobacillus plantarum PM1 versus placebo as a prophylaxis for recurrence urinary tract infections in children: a study protocol for a randomised controlled trial
Received: 22 February 2020
Accepted: 17 September 2020
First Online: 23 October 2020
Ethics approval and consent to participate
: The Bioethics Committee of Medical University of Warsaw approved the study protocol, the comittee’ reference number is KB/6/2018.
: Not applicable.
: The Miralex company had no input into the design of the trial. The authors have no competing financial or no-financial interests.